vs

Side-by-side financial comparison of GCL Global Holdings Ltd (GCL) and SI-BONE, Inc. (SIBN). Click either name above to swap in a different company.

GCL Global Holdings Ltd is the larger business by last-quarter revenue ($98.7M vs $56.3M, roughly 1.8× SI-BONE, Inc.). SI-BONE, Inc. runs the higher net margin — -2.9% vs -5.2%, a 2.2% gap on every dollar of revenue. SI-BONE, Inc. produced more free cash flow last quarter ($440.0K vs $-5.2M).

GCL Global Holdings Ltd is a leading clean energy enterprise focusing on R&D, production and operation of photovoltaic products, energy storage systems and low-carbon energy solutions. Its main markets cover Asia, Europe, North America, serving utility, commercial and residential distributed energy users across the globe.

Bone Clones, Inc. manufactures, distributes, and sells osteological reproductions of human and animal bones. Located in Chatsworth, California, Bone Clones provides these reproductions to museums, universities, medical schools, and other educational institutions.

GCL vs SIBN — Head-to-Head

Bigger by revenue
GCL
GCL
1.8× larger
GCL
$98.7M
$56.3M
SIBN
Higher net margin
SIBN
SIBN
2.2% more per $
SIBN
-2.9%
-5.2%
GCL
More free cash flow
SIBN
SIBN
$5.7M more FCF
SIBN
$440.0K
$-5.2M
GCL

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GCL
GCL
SIBN
SIBN
Revenue
$98.7M
$56.3M
Net Profit
$-5.1M
$-1.6M
Gross Margin
11.0%
79.0%
Operating Margin
-6.7%
-4.4%
Net Margin
-5.2%
-2.9%
Revenue YoY
15.0%
Net Profit YoY
63.4%
EPS (diluted)
$-0.04
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GCL
GCL
SIBN
SIBN
Q4 25
$56.3M
Q3 25
$98.7M
$48.7M
Q2 25
$142.1M
$48.6M
Q1 25
$47.3M
Q4 24
$49.0M
Q3 24
$36.1M
$40.3M
Q2 24
$40.0M
Q1 24
$37.9M
Net Profit
GCL
GCL
SIBN
SIBN
Q4 25
$-1.6M
Q3 25
$-5.1M
$-4.6M
Q2 25
$5.6M
$-6.2M
Q1 25
$-6.5M
Q4 24
$-4.5M
Q3 24
$-1.9M
$-6.6M
Q2 24
$-8.9M
Q1 24
$-10.9M
Gross Margin
GCL
GCL
SIBN
SIBN
Q4 25
79.0%
Q3 25
11.0%
79.8%
Q2 25
15.0%
79.8%
Q1 25
79.7%
Q4 24
79.1%
Q3 24
16.2%
79.1%
Q2 24
79.0%
Q1 24
78.9%
Operating Margin
GCL
GCL
SIBN
SIBN
Q4 25
-4.4%
Q3 25
-6.7%
-11.1%
Q2 25
2.3%
-14.4%
Q1 25
-15.8%
Q4 24
-11.2%
Q3 24
-5.6%
-18.9%
Q2 24
-25.2%
Q1 24
-31.8%
Net Margin
GCL
GCL
SIBN
SIBN
Q4 25
-2.9%
Q3 25
-5.2%
-9.4%
Q2 25
3.9%
-12.7%
Q1 25
-13.8%
Q4 24
-9.2%
Q3 24
-5.2%
-16.3%
Q2 24
-22.4%
Q1 24
-28.8%
EPS (diluted)
GCL
GCL
SIBN
SIBN
Q4 25
$-0.04
Q3 25
$-0.04
$-0.11
Q2 25
$0.05
$-0.14
Q1 25
$-0.15
Q4 24
$-0.10
Q3 24
$-0.16
Q2 24
$-0.22
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GCL
GCL
SIBN
SIBN
Cash + ST InvestmentsLiquidity on hand
$16.6M
$42.2M
Total DebtLower is stronger
$52.0M
$35.6M
Stockholders' EquityBook value
$33.1M
$177.5M
Total Assets
$159.9M
$238.6M
Debt / EquityLower = less leverage
1.57×
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GCL
GCL
SIBN
SIBN
Q4 25
$42.2M
Q3 25
$16.6M
$26.5M
Q2 25
$18.2M
$34.1M
Q1 25
$41.2M
Q4 24
$34.9M
Q3 24
$2.7M
$30.2M
Q2 24
$25.6M
Q1 24
$32.0M
Total Debt
GCL
GCL
SIBN
SIBN
Q4 25
$35.6M
Q3 25
$52.0M
$35.5M
Q2 25
$11.9M
$35.5M
Q1 25
$35.5M
Q4 24
$35.5M
Q3 24
$36.2M
Q2 24
$36.1M
Q1 24
$36.1M
Stockholders' Equity
GCL
GCL
SIBN
SIBN
Q4 25
$177.5M
Q3 25
$33.1M
$172.1M
Q2 25
$35.9M
$170.3M
Q1 25
$167.3M
Q4 24
$167.0M
Q3 24
$15.9M
$165.0M
Q2 24
$164.7M
Q1 24
$165.5M
Total Assets
GCL
GCL
SIBN
SIBN
Q4 25
$238.6M
Q3 25
$159.9M
$234.3M
Q2 25
$101.6M
$230.9M
Q1 25
$227.3M
Q4 24
$230.4M
Q3 24
$49.6M
$227.0M
Q2 24
$223.8M
Q1 24
$223.7M
Debt / Equity
GCL
GCL
SIBN
SIBN
Q4 25
0.20×
Q3 25
1.57×
0.21×
Q2 25
0.33×
0.21×
Q1 25
0.21×
Q4 24
0.21×
Q3 24
0.22×
Q2 24
0.22×
Q1 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GCL
GCL
SIBN
SIBN
Operating Cash FlowLast quarter
$-4.8M
$1.7M
Free Cash FlowOCF − Capex
$-5.2M
$440.0K
FCF MarginFCF / Revenue
-5.3%
0.8%
Capex IntensityCapex / Revenue
0.4%
2.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GCL
GCL
SIBN
SIBN
Q4 25
$1.7M
Q3 25
$-4.8M
$2.3M
Q2 25
$-10.3M
$173.0K
Q1 25
$-4.9M
Q4 24
$1.2M
Q3 24
$6.1M
$302.0K
Q2 24
$-6.3M
Q1 24
$-7.6M
Free Cash Flow
GCL
GCL
SIBN
SIBN
Q4 25
$440.0K
Q3 25
$-5.2M
$-620.0K
Q2 25
$-10.5M
$-1.9M
Q1 25
$-7.0M
Q4 24
$-1.1M
Q3 24
$-2.7M
Q2 24
$-9.4M
Q1 24
$-9.7M
FCF Margin
GCL
GCL
SIBN
SIBN
Q4 25
0.8%
Q3 25
-5.3%
-1.3%
Q2 25
-7.4%
-4.0%
Q1 25
-14.8%
Q4 24
-2.2%
Q3 24
-6.8%
Q2 24
-23.6%
Q1 24
-25.5%
Capex Intensity
GCL
GCL
SIBN
SIBN
Q4 25
2.3%
Q3 25
0.4%
6.1%
Q2 25
0.1%
4.3%
Q1 25
4.4%
Q4 24
4.6%
Q3 24
7.5%
Q2 24
7.8%
Q1 24
5.5%
Cash Conversion
GCL
GCL
SIBN
SIBN
Q4 25
Q3 25
Q2 25
-1.84×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GCL
GCL

Segment breakdown not available.

SIBN
SIBN

US$53.5M95%
Non Us$2.9M5%

Related Comparisons